Perforinopathy: A spectrum of human immune disease caused by defective perforin delivery or function

Frontiers in Immunology

Volumn 4, Issue DEC, 2013, Pages

  Voskoboinik, Ilia ^a,b   Trapani, Joseph A ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

FHL; Granzyme; Immune deficiency; NK cell; Perforin; Perforinopathy; Protein misfolding

Indexed keywords

EID: 84892146328     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00441     Document Type: Article

References (52)

1. Law RH, Lukoyanova N, Voskoboinik I, Caradoc-Davies TT, Baran K, Dunstone MA, et al. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature (2010) 468:447-51. doi: 10.1038/nature09518.
2. Baran K, Dunstone M, Chia J, Ciccone A, Browne KA, Clarke CJ, et al. The molecular basis for perforin oligomerization and transmembrane pore assembly. Immunity (2009) 30:684-95. doi:10.1016/j.immuni.2009.03.016.
3. Peters PJ, Borst J, Oorschot V, Fukuda M, Krahenbuhl O, Tschopp J, et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med (1991) 173:1099-109. doi:10.1084/jem.173.5.1099.
4. de Saint Basile G, Gaël Ménasché G, Fischer A. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol (2010) 11:568-79. doi:10.1038/nri2803.
5. Lopez JA, Susanto O, Jenkins MR, Lukoyanova N, Sutton VR, Law RH, et al. Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood (2013) 121:2659-68. doi:10.1182/blood-2012-07-446146.
6. Lopez JA, Jenkins MR, Rudd-Schmidt JA, Brennan AJ, Danne JC, Mannering SI, et al. Rapid and unidirectional perforin pore delivery at the cytotoxic immune synapse. J Immunol (2013) 191:2328-34. doi:10.4049/jimmunol.1301205.
7. Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, et al. Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A (1994) 91:10854-8. doi:10.1073/pnas.91.23.10854.
8. Su B, Bochan MR, Hanna WL, Froelich CJ, Brahmi Z. Human granzyme B is essential for DNA fragmentation of susceptible target cells. Eur J Immunol (1994) 24:2073-80. doi:10.1002/eji.1830240921.
9. Shiver JW, Su L, Henkart PA. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell (1992) 71:315-22. doi:10.1016/0092-8674(92)90359-K.
10. Shi L, Kraut RP, Aebersold R, Greenberg AH. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med (1992) 175:553-66. doi:10.1084/jem.175.2.553.
11. Shi L, Kam CM, Powers JC, Aebersold R, Greenberg AH. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med (1992) 176:1521-9. doi:10.1084/jem.176.6.1521.
12. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell (1994) 76:977-87. doi:10.1016/0092-8674(94)90376-X.
13. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 286:1957-9. doi:10.1126/science.286.5446.1957.
14. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med (2012) 63:233-46. doi:10.1146/annurev-med-041610-134208.
15. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer (2007) 48:124-31. doi:10.1002/pbc.21039.
16. Zoller EE, Lykens JE, Terrell CE, Aliberti J, Filipovich AH, Henson PM, et al. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med (2011) 208:1203-14. doi:10.1084/jem.20102538.
17. Ohadi M, Lalloz MR, Sham P, Zhao J, Dearlove AM, Shiach C, et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet (1999) 64:165-71. doi:10.1086/302187.
18. zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet (2005) 14:827-34. doi:10.1093/hmg/ddi076.
19. zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet (2009) 85:482-92. doi:10.1016/j.ajhg.2009.09.005.
20. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell (2003) 115:461-73. doi:10.1016/S0092-8674(03)00855-9.
21. Cote M, Menager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, et al. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest (2009) 119:3765-73. doi:10.1172/JCI40732.
22. Clementi R, Locatelli F, Dupre L, Garaventa A, Emmi L, Bregni M, et al. A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood (2005) 105:4424-8. doi:10.1182/blood-2004-04-1477.
23. Chia J, Yeo KP, Whisstock JC, Dunstone MA, Trapani JA, Voskoboinik I. Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer. Proc Natl Acad Sci U S A (2009) 106:9809-14. doi:10.1073/pnas.0903815106.
24. Trapani JA, Thia KYT, Andrews M, Davis ID, Gedye C, Parente P, et al. Human perforin mutations and susceptibility to multiple primary cancers. Oncoimmunology (2013) 2:e24185. doi:10.4161/onci.24185.
25. Anthony DA, Andrews DM, Chow M, Watt SV, House C, Akira S, et al. A role for granzyme M in TLR4-driven inflammation and endotoxicosis. J Immunol (2010) 185:1794-803. doi:10.4049/jimmunol.1000430.
26. Anthony DA, Andrews DM, Watt SV, Trapani JA, Smyth MJ. Functional dissection of the granzyme family: cell death and inflammation. Immunol Rev (2010) 235:73-92. doi:10.1111/j.0105-2896.2010.00907.x.
27. Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, Freudenberg M, et al. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity (2008) 29:720-33. doi:10.1016/j.immuni.2008.08.014.
28. Thia KY, Trapani JA. The granzyme B gene is highly polymorphic in wild mice but essentially invariant in common inbred laboratory strains. Tissue Antigens (2007) 70:198-204. doi:10.1111/j.1399-0039.2007.00872.x.
29. McIlroy D, Cartron PF, Tuffery P, Dudoit Y, Samri A, Autran B, et al. A triple-mutated allele of granzyme B incapable of inducing apoptosis. Proc Natl Acad Sci U S A (2003) 100:2562-7. doi:10.1073/pnas.0437935100.
30. Chia J, Thia K, Brennan AJ, Little M, Williams B, Lopez JA, et al. Fatal immune dysregulation due to a gain of glycosylation mutation in lymphocyte perforin. Blood (2012) 119:1713-6. doi:10.1182/blood-2011-08-374355.
31. Voskoboinik I, Sutton VR, Ciccone A, House CM, Chia J, Darcy PK, et al. Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood (2007) 110:1184-90. doi:10.1182/blood-2007-02-072850.
32. Voskoboinik I, Thia M-C, De Bono A, Browne K, Cretney E, Jackson JT, et al. The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene. J Exp Med (2004) 200:811-6. doi:10.1084/jem.20040776.
33. Voskoboinik I, Thia MC, Trapani JA. A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood (2005) 105:4700-6. doi:10.1182/blood-2004-12-4935.
34. Sieni E, Cetica V, Santoro A, Beutel K, Mastrodicasa E, Meeths M, et al. Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3. J Med Genet (2011) 48:343-52. doi:10.1136/jmg.2010.085456.
35. Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, et al. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood (2012) 119:6016-24. doi:10.1182/blood-2011-12-398958.
36. Al-Jasmi F, Abdelhaleem M, Stockley T, Lee K-S, Clarke JTR. Novel mutation of the perforin gene and maternal uniparental disomy 10 in a patient with familial hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol (2008) 30:621-4. doi:10.1097/MPH.0b013e31817580fd.
37. Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol (2006) 6:940-52. doi:10.1038/nri1983.
38. Busiello R, Adriani M, Locatelli F, Galgani M, Fimiani G, Clementi R, et al. Atypical features of familial hemophagocytic lymphohistiocytosis. Blood (2004) 103:4610-2. doi:10.1182/blood-2003-10-3551.
39. Clementi R, Emmi L, Maccario R, Liotta F, Moretta L, Danesino C, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood (2002) 100:2266-7. doi:10.1182/blood-2002-04-1030.
40. Zur Stadt U, Beutel K, Weber B, Kabisch H, Schneppenheim R, Janka G, et al. A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype. Blood (2004) 104:1909-10. doi:10.1182/blood-2004-02-0733.
41. Trambas C, Gallo F, Pende D, Marcenaro S, Moretta L, De Fusco C, et al. A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. Blood (2005) 106:932-7. doi:10.1182/blood-2004-09-3713.
42. Orilieri E, Cappellano G, Clementi R, Cometa A, Ferretti M, Cerutti E, et al. Variations of the perforin gene in patients with type 1 diabetes. Diabetes (2008) 57:1078-83. doi:10.2337/db07-0947.
43. Mehta PA, Davies SM, Kumar A, Devidas M, Lee S, Zamzow T, et al. Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia (2006) 20:1539-41. doi:10.1038/sj.leu.2404299.
44. Cappellano G, Orilieri E, Comi C, Chiocchetti A, Bocca S, Boggio E, et al. Variations of the perforin gene in patients with multiple sclerosis. Genes Immun (2008) 9:438-44. doi:10.1038/gene.2008.35.
45. Voskoboinik I, Dunstone MA, Baran K, Whisstock JC, Trapani JA. Perforin: structure, function, and role in human immunopathology. Immunol Rev (2010) 235:35-54. doi:10.1111/j.0105-2896.2010.00896.X.
46. Beaty AD, Weller C, Levy B, Vogler C, Ferguson WS, Bicknese A, et al. A teenage boy with late onset hemophagocytic lymphohistiocytosis with predominant neurologic disease and perforin deficiency. Pediatr Blood Cancer (2007) 50:1070-2. doi:10.1002/pbc.21438.
47. Katano H, Ali MA, Patera AC, Catalfamo M, Jaffe ES, Kimura H, et al. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood (2004) 103:1244-52. doi:10.1182/blood-2003-06-2171.
48. Cannella S, Santoro A, Bruno G, Pillon M, Mussolin L, Mangili G, et al. Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma. Cancer (2007) 109:2566-71. doi:10.1002/cncr.22718.
49. Santoro A, Cannella S, Trizzino A, Lo Nigro L, Corsello G, Arico M. A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia? Haematologica (2005) 90:697-8.
50. Brennan AJ, Chia J, Browne KA, Ciccone A, Ellis S, Lopez JA, et al. Protection from endogenous perforin: glycans and the C terminus regulate exocytic trafficking in cytotoxic lymphocytes. Immunity (2011) 34:879-92. doi:10.1016/j.immuni.2011.04.007.
51. Gartner JJ, Parker SC, Prickett TD, Dutton-Regester K, Stitzel ML, Lin JC, et al. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc Natl Acad Sci U S A (2013) 110:13481-6. doi:10.1073/pnas.1304227110.
52. Machaczka M, Klimkowska M, Chiang SC, Meeths M, Muller ML, Gustafsson B, et al. Development of classical Hodgkin's lymphoma in an adult with biallelic STXBP2 mutations. Haematologica (2013) 98:760-4. doi:10.3324/haematol.2012.073098.